Navigation Links
Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
Date:2/24/2011

news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer Web site at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

This news release contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding the progress and results of the clinical development, safety, regulatory processes, commercialization efforts or commercial potential of Nexavar. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including risks related to the development and commercialization of pharmaceutical products. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2010, filed with the Securities and Exchange Commission under the heading "Risk Factors" and Onyx's Quarterly Reports on Form 10-Q for a more detailed description of such factors. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release. Onyx undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Israel , Feb. 26, 2015 Integrity ... of the GlucoTrack ® model DF-F, a noninvasive  device ... Lutz Heinemann , Ph.D., will head its new ... opinion leaders in the field of Diabetes research, monitoring ... , Ph.D has been Chief Executive Officer and Head, ...
(Date:2/26/2015)... , Feb. 26, 2015  CSSi, ( www.CSSiEnroll.com ... the clinical research industry, is pleased to announce ... as a Project Manager, adding significant value and ... - http://photos.prnewswire.com/prnh/20150225/177750 Karen ... demonstrated ability to successfully lead the navigation of ...
(Date:2/26/2015)... Feb. 26, 2015  Technological advancements have ... effective, inexpensive and compact yet powerful solutions. ... small-scale, potent devices, lending momentum to the ... http://photos.prnewswire.com/prnh/20150225/177944LOGO New ... Nanomanufacturing, finds that nanomanufacturing will gain traction ...
Breaking Medicine Technology:Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 4CSSi's Continued Growth Brings Talented New Hire - Karen Welch Welcomed as Project Manager 2Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 2Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 3Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 4
... Phase I data from XL880, Phase II data from ... SOUTH SAN FRANCISCO, May 30, 2007 /PRNewswire-FirstCall/ --,Exelixis, Inc. ... investigational compounds XL880 and XL999 will be,presented at the ... is being held June 1 to 5 in Chicago,Illinois. ...
... many as,first-line in secondary stroke prevention , ... presented today at the,16th European Stroke Conference in ... dipyridamole plus ASA,is marketed as Aggrenox® or Asasantin® ... vascular events in patients who had,a TIA or ...
Cached Medicine Technology:Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 3New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 4
(Date:2/26/2015)... Los Angeles, CA (PRWEB) February 26, 2015 ... to live stream his hair transplant contest winner’s ... and preparation, the winner Marc R., is all set to ... transplant using the ARTAS system. His procedure will be done ... Parsa Mohebi website. To watch the surgery, go to the ...
(Date:2/26/2015)... Imagine a day without access to clean, ... and there was no one to help. For more than ... In 2015, more than 2.5 billion people will also lack ... A new initiative led by Nevada’s Desert Research Institute ... specifically on women – who often bear the brunt of ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Thousands of ... step to fund powerful progress for the Muscular Dystrophy ... raising critical funds and awareness that will help save ... muscle disease. , “MDA Muscle Walk events unite and ... people whose abilities to move are compromised — including ...
(Date:2/26/2015)... 2015 Wound Care Advantage ... expanded its executive team by adding three key members ... the same time two WCA team members were promoted ... (WCA) was founded in 2002 and is one of ... The WCA team believes that providing outstanding patient care ...
(Date:2/26/2015)... PartnerTech Inc . has announced it has been named ... , The Movers & Makers Awards are presented in ... distribution of tangible products and will be held on March ... as Georgia’s largest local awards ceremony for manufacturing and supply ... local industry and business leaders. , “We are thrilled ...
Breaking Medicine News(10 mins):Health News:Hair Transplant Contest Winner’s Surgery to be Streamed LIVE 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 4Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 3
... in Sudan Called "Ground-breaking", DUBAI, United Arab ... billion last fall in an 8-week fundraising drive,Dubai ... the recipients of,its Phase One funding. Dubai Cares ... to improving primary education for,children in developing countries., ...
... of Energy,s Brookhaven National Laboratory have shown that increasing ... chemical, can reduce use of cocaine by 75 percent ... this team had similar findings for alcohol intake. Treatments ... receptors -- may prove useful in treating addiction, according ...
... supports hundreds of programs helping millions in the,developing ... WASHINGTON, April 16 The worldwide,pharmaceutical industry today ... biopharmaceutical companies, global,health leaders and policymakers together to ... developing world., Serving as a convening point ...
... The early use of magnetic resonance imaging (MRI) in ... a better adapted surgical approach to the tumour, a ... today (Wednesday April 16). Dr. David Martinez-Cecilia, a ... Rufian-Pea, in the Hospital Universitario Reina Sofia, Cordoba, Spain, ...
... 15 ECO2 Plastics, Inc.,(OTC Bulletin Board: ECOO), ... plastics are recycled, today reported its 2007 year-end,financial ... revenues of,$4.3 million for calendar year 2007 versus ... versus $14.9 million during the prior,year, with net ...
... to clamp the umbilical cord after a baby is born could ... comes with an increased risk of jaundice, according to a new ... seconds after birth is one of three steps in an active ... a new mother is vulnerable to excessive blood loss. Studies show ...
Cached Medicine News:Health News:Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations 2Health News:Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations 3Health News:Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations 4Health News:Gene therapy reduces cocaine use in rats 2Health News:Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries 2Health News:Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries 3Health News:MRI before surgery leads to better-adapted treatment for breast cancer 2Health News:ECO2 Plastics, Inc. Reports 2007 Year End Financial Results, Announces FDA Filing and Provides Outlook for 2008 2Health News:ECO2 Plastics, Inc. Reports 2007 Year End Financial Results, Announces FDA Filing and Provides Outlook for 2008 3Health News:Health risks, benefits come with delayed umbilical cord clamping 2
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
... Triad Plus Skin Protectant Swabsticks prepare the ... or bandage. When dry, they leave a ... provides a clean surface and a barrier ... the adhesion of a dressing or tape ...
... Triad Plus BZK ... Chloride solution and are ... Benzalkonium Chloride (BZK) may ... gentle cleansing solution is ...
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
Medicine Products: